UnitedHealth Group Reaches Agreement with FTC on Insulin Pricing Dispute
Subsidiaries of UnitedHealth Group, including OptumRx and Emisar Pharma Services, have reached a tentative agreement with the Federal Trade Commission to settle allegations involving anticompetitive insulin pricing practices. The proposed settlement could resolve regulatory concerns surrounding rebating strategies used by these entities.
Topics: FTC settlement healthcare insulin pricing